News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
540,180 Results
Type
Article (27253)
Company Profile (385)
Press Release (512516)
Multimedia
Podcasts (108)
Webinars (20)
Section
Business (148378)
Career Advice (884)
Deals (25885)
Drug Delivery (82)
Drug Development (67033)
Employer Resources (97)
FDA (12548)
Job Trends (11154)
News (253048)
Policy (19527)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2111)
Accelerated approval (39)
Adcomms (18)
Allergies (147)
Alliances (41487)
ALS (193)
Alzheimer's disease (1564)
Antibody-drug conjugate (ADC) (448)
Approvals (12965)
Artificial intelligence (669)
Autoimmune disease (248)
Automation (54)
Bankruptcy (194)
Best Places to Work (9711)
BIOSECURE Act (12)
Biosimilars (170)
Biotechnology (286)
Bladder cancer (176)
Brain cancer (68)
Breast cancer (702)
Cancer (5536)
Cardiovascular disease (414)
Career advice (791)
Career pathing (25)
CAR-T (318)
CDC (22)
Celiac Disease (1)
Cell therapy (870)
Cervical cancer (44)
Clinical research (58834)
Collaboration (2095)
Company closure (7)
Compensation (1056)
Complete response letters (73)
COVID-19 (1854)
CRISPR (109)
C-suite (1050)
Cystic fibrosis (150)
Data (7168)
Decentralized trials (3)
Denatured (30)
Depression (156)
Dermatology (73)
Diabetes (478)
Diagnostics (5696)
Digital health (50)
Diversity (7)
Diversity, equity & inclusion (31)
Drug discovery (319)
Drug pricing (96)
Drug shortages (13)
Duchenne muscular dystrophy (277)
Earnings (59474)
Editorial (39)
Employer branding (11)
Employer resources (89)
Events (89170)
Executive appointments (1049)
FDA (16013)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1702)
Gene editing (242)
Generative AI (56)
Gene therapy (692)
GLP-1 (770)
Government (2681)
Grass and pollen (4)
Guidances (373)
Healthcare (15278)
HIV (68)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (259)
Immuno-oncology (87)
Indications (171)
Infectious disease (2126)
Inflammatory bowel disease (210)
Inflation Reduction Act (11)
Influenza (119)
Intellectual property (263)
Interviews (130)
IPO (12693)
IRA (19)
Job creations (1827)
Job search strategy (664)
JPM (53)
Kidney cancer (20)
Labor market (48)
Layoffs (374)
Leadership (26)
Legal (3254)
Liver cancer (92)
Longevity (30)
Lung cancer (756)
Lymphoma (377)
Machine learning (57)
Management (32)
Manufacturing (882)
MASH (180)
Medical device (11356)
Medtech (11450)
Mergers & acquisitions (14378)
Metabolic disorders (1221)
mRNA (185)
Multiple sclerosis (163)
NASH (18)
Neurodegenerative disease (383)
Neuropsychiatric disorders (96)
Neuroscience (2970)
Neurotech (1)
NextGen: Class of 2026 (5159)
Non-profit (3187)
Now hiring (47)
Obesity (522)
Opinion (231)
Ovarian cancer (206)
Pain (240)
Pancreatic cancer (283)
Parkinson's disease (352)
Partnered (31)
Patents (524)
Patient recruitment (623)
Peanut (56)
People (46504)
Pharmaceutical (52)
Pharmacy benefit managers (21)
Phase 1 (19587)
Phase 2 (26507)
Phase 3 (18576)
Pipeline (7561)
Policy (173)
Postmarket research (1438)
Preclinical (8130)
Press Release (55)
Prostate cancer (285)
Psychedelics (58)
Radiopharmaceuticals (322)
Rare diseases (1006)
Real estate (3906)
Recruiting (35)
Regulatory (18194)
Reports (28)
Research institute (2073)
Resumes & cover letters (108)
Rett syndrome (36)
RNA editing (26)
RSV (63)
Schizophrenia (169)
Series A (293)
Series B (214)
Service/supplier (9)
Sickle cell disease (109)
Special edition (21)
Spinal muscular atrophy (144)
Sponsored (43)
Startups (2980)
State (2)
Stomach cancer (17)
Supply chain (102)
Tariffs (36)
The Weekly (76)
Vaccines (705)
Venture capital (100)
Weight loss (295)
Women's health (103)
Worklife (9)
Date
Last 7 days (695)
Last 30 days (2437)
Last 365 days (27918)
2026 (9861)
2025 (27983)
2024 (32086)
2023 (35934)
2022 (45761)
2021 (48585)
2020 (45202)
2019 (37067)
2018 (27468)
2017 (26082)
2016 (23825)
2015 (27676)
2014 (20675)
2013 (16392)
2012 (17193)
2011 (17226)
2010 (15291)
Location
Africa (436)
Alabama (95)
Alaska (6)
Arizona (212)
Arkansas (13)
Asia (31253)
Australia (5049)
California (11927)
Canada (3133)
China (1256)
Colorado (514)
Connecticut (531)
Delaware (370)
Europe (71994)
Florida (1764)
Georgia (401)
Hawaii (3)
Idaho (49)
Illinois (876)
India (79)
Indiana (578)
Iowa (22)
Japan (495)
Kansas (124)
Kentucky (48)
Louisiana (31)
Maine (44)
Maryland (1327)
Massachusetts (8658)
Michigan (319)
Minnesota (651)
Mississippi (7)
Missouri (143)
Montana (36)
Nebraska (18)
Nevada (120)
New Hampshire (80)
New Jersey (3044)
New Mexico (28)
New York (3076)
North Carolina (1601)
North Dakota (10)
Northern California (5922)
Ohio (379)
Oklahoma (26)
Oregon (43)
Pennsylvania (2366)
Puerto Rico (22)
Rhode Island (47)
South America (659)
South Carolina (80)
South Dakota (2)
Southern California (4699)
Tennessee (170)
Texas (1850)
United States (41863)
Utah (302)
Vermont (1)
Virginia (287)
Washington D.C. (62)
Washington State (938)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
540,180 Results for "hitachi chemical advanced therapeutics solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026
April 21, 2026
·
5 min read
Press Releases
BlossomHill Therapeutics Presents First Preclinical Data from New Pan-KRAS Inhibitor Program Built on a Novel Chemical Scaffold During Mini Symposium at AACR 2026
April 22, 2026
·
5 min read
Press Releases
Biora Therapeutics Advances BioJet™ Swallowable Autoinjector
April 8, 2026
·
3 min read
Press Releases
1910 Publishes CANDID-CNS™, an AI Model That Unlocks Beyond Rule of 5 Chemical Space and Stereochemistry to Predict Blood–Brain Barrier Penetration
● CANDID-CNS™ is the new state-of-the-art AI model for BBB penetration: it achieves 87% AUPRC on bRo5 small molecules compared to 56% by Pfizer’s CNS MPO. ● CANDID-CNS™ distinguishes CNS penetrant stereoisomers at 68% compared to 50% by Pfizer’s CNS MPO. ● Published in the Journal of Chemical Information and Modeling, CANDID-CNS™ presents a breakthrough in AI Drug Discovery by unlocking the potential of bRo5 and stereochemistry to significantly expand the chemical space of small molecules that can be developed into CNS therapeutics.
December 4, 2025
·
1 min read
Press Releases
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera
April 27, 2026
·
6 min read
Press Releases
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
April 20, 2026
·
6 min read
Press Releases
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
April 17, 2026
·
4 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
April 23, 2026
·
6 min read
Press Releases
Brenig Therapeutics to Present Hybrid AI Drug Discovery Platform at Keystone Symposia Computational Advances in Drug Discovery
April 30, 2026
·
4 min read
Press Releases
BioLab Holdings Announces Investment in Advanced Synthetic Antimicrobial -Tissue Regeneration Solutions
January 28, 2026
·
3 min read
1 of 54,018
Next
